|
CLINICAL AND IMMUNOLOGICAL EFFICIENCY "IMUNOFAN" IN THE TREATMENT OF NUMMULAR MICROBIAL ECZEMA
|
|
| Author:
|
Z.R. KHISMATULLINA, N.A. NADYRCHENKO
|
| Abstract:
|
Nummular microbial eczema is characterized by a severe, often relapsing course with resistance to standard
therapies, which leads to an increase in cases of temporary disability and the need for hospitalization of patients. The
aim of the study was to evaluate the clinical and immunological effectiveness of the immunomodulator Imunofan in the
treatment of moderate nummular microbial eczema to substantiate its practical application. 80 patients, among them
50 women (62.5%) and 30 men (37.5%) aged from 35 to 56 years old were included in the main group, where
complex therapy was applied. The control group, where standard therapy was applied, included 104 patients, among
them 62 women (59.6%) and 42 men (40.4%) aged 35 to 56 years. The group of healthy donors included 50 people:
32 women (64%) and 18 men (46%) aged 35 to 55 years. Evaluation of the clinical efficacy of the treatment was
carried out using the index of severity of microbial eczema and the dermatological quality of life index, the
quantitative determination of TNF-a in serum was performed by enzyme immunoassay. The results of the study
showed that the use of the immunomodulator Imunofan in the complex therapy of patients with moderately severe
nummular microbial eczema reduced the activity of the inflammatory process in the skin by reducing the amount of
TNF-a in the blood serum, obtaining a positive dynamic of the clinical picture, reducing the risk of recurrence and
reduce the time of hospitalization.
|
| Keyword:
|
nummular microbial eczema, imunofan, TNF-a, index of severity of microbial eczema, dermatological index of quality of life.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2019.11.03.068
|
| Download:
|
Request For Article
|
|
|